Gerard Griffioen
Direttore Tecnico/Scientifico/R&S presso reMYND NV
Posizioni attive di Gerard Griffioen
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
reMYND NV
 reMYND NV Miscellaneous Commercial ServicesCommercial Services reMYND NV engages in the development of disease-modifying treatments against alzheimer's, parkinson's, diabetes and other protein misfolding disorders. Its drug and development unit focuses on innovative, disease-modifying drugs for treating degenerative disorders. The company was founded by Fred Van Leuven, Stefaan Wera and Joris Winderickx in 2002 and is headquartered in Leuven, Belgium. | Direttore Tecnico/Scientifico/R&S | - | - |
Storia della carriera di Gerard Griffioen
Precedenti posizioni note di Gerard Griffioen
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| Katholieke Universiteit Leuven | Corporate Officer/Principal | - | - |
| University of Vienna | Corporate Officer/Principal | - | - |
Formazione di Gerard Griffioen
| Vrije Universiteit Amsterdam | Doctorate Degree |
Statistiche
Distribuzione geografica
| Belgio | 3 |
| Regno Unito | 2 |
| Austria | 2 |
Posizioni
| Corporate Officer/Principal | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
| Doctorate Degree | 1 |
Settori
| Consumer Services | 4 |
| Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 1 |
|---|---|
reMYND NV
reMYND NV Miscellaneous Commercial ServicesCommercial Services reMYND NV engages in the development of disease-modifying treatments against alzheimer's, parkinson's, diabetes and other protein misfolding disorders. Its drug and development unit focuses on innovative, disease-modifying drugs for treating degenerative disorders. The company was founded by Fred Van Leuven, Stefaan Wera and Joris Winderickx in 2002 and is headquartered in Leuven, Belgium. | Commercial Services |
- Borsa valori
- Insiders
- Gerard Griffioen
- Esperienza
